SPIA
ROIV icon

Steward Partners Investment Advisory’s Roivant Sciences ROIV Stock Holding History

Steward Partners Investment Advisory’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-344
Closed -$9.53K – 4834
2026
Q1 		$9.53K Buy
+344
New +$8.84K ﹤0.01% 3585
2025
Q1 		– Sell
-21,953
Closed -$260K – 4137
2024
Q4 		$260K Buy
+21,953
New +$260K ﹤0.01% 1478

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Steward Partners Investment Advisory's ROIV Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 344 shares — an estimated $9.53K sold.

Steward Partners Investment Advisory first reported a position in ROIV in Q4 2024 and held it in 2 quarters. The position peaked at $260K in Q4 2024. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Steward Partners Investment Advisory reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 344 Roivant Sciences shares in Q2 2026, an estimated $9.53K.
  • Steward Partners Investment Advisory first reported a position in Roivant Sciences in Q4 2024 and held it in 2 quarters.
  • Steward Partners Investment Advisory's Roivant Sciences position peaked at $260K in Q4 2024.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.